Bifidobacterium animalis subsp. lactis Bi-07 and Reduced Abdominal Pain

• Bifidobacterium animalis subsp. lactis Bi-07 supports lactose digestion in vitro and in randomized, placebo- and lactase-controlled clinical trials

  • 2022-12
  • RCT
  • The American Journal of Clinical Nutrition 116(6)
  • • Pia Rasinkangas
    • S. Forssten
    • M. Marttinen
    • A. Ibarra
    • G. Bothe
    • J. Junnila
    • R. Uebelhack
    • Y. Donazzolo
    • A. Ouwehand

  • PubMed: 36149331
  • DOI: 10.1093/ajcn/nqac264

  5 Insights on

  • Reduced Abdominal Pain

  • High evidence

  Odds of abdominal pain (compared with placebo: 0.32, P = 0.036) and flatulence (compared with placebo: 0.25, P = 0.007) were lower with lactase in Booster Alpha. Increased odds of nausea were seen with Bi-07 (compared with placebo: 4.0, P = 0.005) in Booster Omega.

  Effect

  Neutral

  Effect size

  Small

  Significant

  No

  Dose

  2 × 10^12 CFUs